Dianthus Therapeutics to participate in five investor conferences
DNTH•Dianthus Therapeutics will participate in five healthcare and biopharma investor conferences from Nov. 9 to Nov. 18, 2026, with four scheduled fireside chats and one-on-one investor meetings.
1. Conference schedule
Dianthus Therapeutics will attend the Guggenheim Healthcare Innovation Conference on Nov. 9, 2026, with a fireside chat at 11:00 a.m. ET. CEO Marino Garcia will participate in a Stifel Healthcare Conference fireside chat on Nov. 11 at 9:20 a.m. ET, while Ryan Savitz, executive vice president, CFO and CBO, will hold one-on-one investor meetings at the Truist Securities BioPharma Symposium on Nov. 12.
2. Later appearances
The company is scheduled for a UBS Global Biopharma Conference fireside chat on Nov. 16 at 9:20 a.m. GMT and a Jefferies Global Healthcare Conference fireside chat on Nov. 18 at 2:30 p.m. GMT.
